ArticleFrontiers in oncology2021

A First-In-Class, Humanized Antibody Targeting Alternatively Spliced Tissue Factor: Preclinical Evaluation in an Orthotopic Model of Pancreatic Ductal Adenocarcinoma.

Clayton S Lewis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.